SCHEMBL2215974

SCHEMBL2215974

NC(=O)C(c1ccccc1)(c1cccnc1)n1cnc2cccnc21

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.38
TP53 P04637 1/20 0.38
PABPC1 P11940 1/20 0.38
KMT2A Q03164 1/20 0.38
KCNA5 P22460 6/20 0.36
CYP3A4 P08684 3/20 0.35
CYP1A2 P05177 2/20 0.35
LMNA P02545 1/20 0.35
CYP11B1 P15538 1/20 0.35
CYP11B2 P19099 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
F7 P08709 1/20 0.34
F3 P13726 1/20 0.34
SARM1 Q6SZW1 1/20 0.34
SIRT2 Q8IXJ6 1/20 0.34
SIRT6 Q8N6T7 1/20 0.34
SIRT1 Q96EB6 1/20 0.34
SIRT3 Q9NTG7 1/20 0.34
SIRT5 Q9NXA8 1/20 0.34
SIRT4 Q9Y6E7 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2220624 0.77 MAPT (0.41) MEN1TP53PABPC1KMT2APARP1
SCHEMBL2221713 0.77 TP53 (0.40) MEN1TP53PABPC1KMT2APARP1
SCHEMBL15157324 0.73 MEN1 (0.43) MEN1TP53PABPC1KMT2AKCNA5
SCHEMBL2193745 0.71 ASAH1 (0.39) MEN1TP53PABPC1KMT2ACYP3A4
SCHEMBL17592012 0.68 KCNN4 (0.56) MEN1KMT2AKCNA5CYP3A4CYP1A2
SCHEMBL29908323 0.68 PARP1 (0.56) MEN1TP53PABPC1KMT2APARP1
Carbamic Acid SCHEMBL17892698 0.68 CYP1A2 (0.40) MEN1KMT2ACYP3A4CYP1A2LMNA
SCHEMBL2715939 0.66 KMT2A (0.50) MEN1TP53PABPC1KMT2ALMNA
SCHEMBL30814447 0.66 KMT2A (0.50) MEN1TP53PABPC1KMT2ALMNA
SCHEMBL26133831 0.66 LMNA (0.51) KMT2AKCNA5CYP3A4CYP1A2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110172203-A1 Substituted Imidazopyridinyl-Aminopyridine Compounds ARQULE, INC. (US) 2011-07-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110172203-A1 Substituted Imidazopyridinyl-Aminopyridine Compounds MKI67, CDK4, ABL1 MEN1 1121/4885TP53 4/4885PABPC1 870/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.